$350.00 Original price was: $350.00.$200.00Current price is: $200.00.
Retatrutide is a 39-amino acid synthetic peptide and triple agonist of the GLP-1, GIP, and glucagon receptors developed to modulate metabolic rate, hunger signaling, and glucose homeostasis through simultaneous activation of the GLP-1R, GIPR, and GCGR pathways. It is utilized in metabolic research examining multi-receptor synergy in adiposity reduction, the physiological impact of glucagon-mediated energy expenditure, and peptide-driven glycemic control in type 2 diabetes models.
For research use only. Not for human consumption.
Shipping & Delivery Information
Our peptides undergo a careful handling, verification, and packaging process to ensure quality and integrity before shipment.
Delivery time typically ranges from 3 to 15 business days, depending on your location and the shipping method selected at checkout.
Once your payment is confirmed, you will receive tracking information so you can monitor your order every step of the way.
We are committed to delivering your order as quickly as possible while maintaining the highest standards of quality and care.
RETATRUTIDE is an investigational research peptide designed to study advanced metabolic regulation pathways. This multi-receptor agonist is being explored in preclinical and clinical research for its interaction with GLP-1, GIP, and glucagon receptors, making it a subject of interest in metabolic science, energy expenditure, and body composition research.
Current research is investigating its potential role in metabolic signaling, appetite regulation, glucose homeostasis, fat metabolism, and energy balance mechanisms.
Retratrutide is widely used in scientific research focused on obesity mechanisms, insulin signaling, metabolic adaptation, and next-generation incretin-based therapies.
For research use only. Not for human consumption.
Our peptides undergo a meticulous handling, verification, and packaging process to maintain product quality and integrity prior to shipment.
Delivery times generally range from 3–15 business days, depending on destination and shipping method selected at checkout.
Once payment is confirmed, tracking details will be provided so you can monitor your shipment throughout delivery.
We are committed to providing fast, secure, and reliable fulfillment while maintaining the highest standards of quality.
Proper handling is essential to preserve peptide stability and integrity.
Lyophilized Product:
Store frozen at −20°C (−4°F) or below in a dry, dark environment.
After Reconstitution:
Store refrigerated at 2–8°C (35.6–46.4°F) and protect from light.
Avoid repeated freeze-thaw cycles.
Use sterile laboratory handling procedures when preparing research materials.
General laboratory reconstitution guidance:
Important: This information is provided for laboratory educational purposes only and does not constitute medical advice.
Retratrutide is being studied in research involving:
✔ Metabolic regulation
✔ Glucose homeostasis mechanisms
✔ Appetite signaling pathways
✔ Energy expenditure research
✔ Adipose tissue metabolism
✔ Insulin sensitivity investigations
✔ Obesity and weight-regulation studies
✔ Next-generation incretin science
Based on emerging scientific investigation, areas of interest include:
Metabolic Health:
Research suggests effects on insulin signaling and glucose metabolism.
Body Composition:
Investigational studies examine its role in fat oxidation, appetite regulation, and energy expenditure.
Energy Balance:
Being explored for effects on caloric regulation and metabolic adaptation.
Cardiometabolic Research:
Interest exists regarding lipid metabolism, inflammatory markers, and metabolic syndrome pathways.
This product is intended strictly for laboratory research purposes only.
Not intended for human use, diagnosis, treatment, or prevention of disease.
Research compounds should only be handled by qualified professionals in appropriate research settings.
| Select | 5MG, 10MG, 20MG, 30MG |
|---|
Research Applications:
The study of Retatrutide is primarily relevant to research questions where triple-receptor agonism is required to address complex metabolic bottlenecks that single or dual agonists may not fully resolve. Example research contexts include:
Energy Expenditure Models: Research focusing on the glucagon receptor (GCGR) component to investigate direct thermogenesis and hepatic lipid metabolism.
Obesity and Satiety Dynamics: Investigation of potent weight loss mechanisms involving coordinated central nervous system signaling and delayed gastric emptying.
Beta-Cell Function and Insulin Sensitivity: Study of the glucose-dependent insulinotropic effects mediated by dual GIP and GLP-1 receptor activation.
Non-alcoholic Fatty Liver Disease (NAFLD): Research into the potential of triple agonism to reduce hepatic fat fraction and improve histologic markers of liver health.
Because “triple agonism” represents a multi-pathway hypothesis, this research frames the compound’s efficacy as a synergistic outcome: if Retatrutide simultaneously modulates nutrient intake (GLP-1/GIP) and energy utilization (Glucagon), preclinical designs may produce superior metabolic improvements compared to monotherapies—specifically in the kinetics of weight reduction and the reversal of insulin resistance—depending on the specific metabolic endpoints and animal models utilized.
⚠️ Important Warnings and Disclaimers
Product Guidelines
Product intended for experimental and research purposes only.
Do not use without proper technical knowledge.
Keep refrigerated as per storage guidelines.
Results may vary based on genetics, diet, and lifestyle.
Keep out of reach of children.
Store according to technical instructions.
Do not reuse vials or materials.
Do not purchase if you have any doubts regarding its use.
Limitation of Liability The company is not responsible for:
Misuse or incorrect administration.
Adverse reactions or interactions with other medications.
Consequences resulting from self-medication.
The buyer assumes full responsibility for all risks associated with handling and utilization.
📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.